SCHEMBL15670800

SCHEMBL15670800

CC(C)OCC(N)CN(Cc1ccccc1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
TSHR P16473 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
PTGES O14684 1/20 0.40
SLC1A3 P43003 2/20 0.40
SLC1A2 P43004 2/20 0.40
SLC1A1 P43005 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15670911 0.84 HPGD (0.52) LMNAHPGDHTTTSHRALDH1A1
SCHEMBL9767585 0.81 GPR88 (0.51) LMNAHPGDMEN1KMT2APTGES
SCHEMBL7996489 0.80 LMNA (0.51) LMNAHPGDTSHRALDH1A1MEN1
Hydrochloric Acid SCHEMBL18342102 0.79 LMNA (0.51) LMNATSHRALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL18342101 0.79 LMNA (0.51) LMNATSHRALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL18342320 0.79 LMNA (0.51) LMNATSHRALDH1A1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL15670740 0.79 CYP2C19 (0.41) LMNATSHRALDH1A1CYP1A2CYP2C9
SCHEMBL15812259 0.78 TDP1 (0.44) LMNAALDH1A1MEN1KMT2A
SCHEMBL6998369 0.75 LMNA (0.53) LMNAHPGDTSHRALDH1A1MEN1
SCHEMBL90032 0.74 ALDH1A1 (0.58) LMNATSHRALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3272749-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE Bayer Pharma Aktiengesellschaft (DE) 2018-01-24 EP disclosed
EP-2914594-B1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE Bayer Pharma AG (DE) 2017-05-03 EP disclosed
EP-2914594-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE Bayer Pharma Aktiengesellschaft (DE) 2015-09-09 EP disclosed
WO-2014068099-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-05-08 WO disclosed